Sarepta Therapeutics (SRPT) Gains on Patent Decision

Sarepta Therapeutics Inc

shares were upped 2.7% to $32.78 after the company reported the USPTO decision in patent interference case with BioMarin Pharmaceutical Inc. Share volume totaled 927,000, compared to an all-day average of 1.2 million